2008k Home Hemodialysis Machine
Fresenius Medical Care North America
FDA Clearance Information
The 2008k home hemodialysis machine was cleared by the FDA via the 510k pathway on July 3, 2013. It is manufactured by Fresenius Medical Care North America and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- For hemodialysis treatment of patients with chronic renal failure or end-stage renal disease.
- For use in the home setting by appropriately trained patients and/or caregivers.
- For use with compatible dialysis supplies, water treatment equipment, and vascular access prescribed for hemodialysis.
Clinical Applications
- Home hemodialysis for patients with end-stage kidney disease.
- Prescribed short daily home hemodialysis treatments.
- Prescribed prolonged or nocturnal home hemodialysis treatments.
- Hemodialysis through an established vascular access, such as an arteriovenous fistula, graft, or dialysis catheter.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The patient and caregiver require training in machine operation, vascular access care, infection prevention, alarm management, and emergency procedures.
- The system requires compatible dialysate supplies, water treatment, electrical service, drainage, and other setup components specified by the manufacturer and dialysis program.
- It is not an MRI device and should not be operated in the MRI scanner room unless the manufacturer and facility have specifically established safe conditions.
- Treatment requires reliable vascular access and medical supervision, including prescriptions for treatment time, blood flow, dialysate settings, and fluid removal.
- Contraindications and warnings depend on the complete system, accessories, patient condition, and dialysis prescription; the current manufacturer instructions and dialysis team guidance should be followed.
Frequently Asked Questions
What are the clinical indications for 2008k home hemodialysis machine?
The device is indicated for patients with end-stage renal disease who require regular hemodialysis and prefer or require treatment in a home setting.
What outcomes have been reported in clinical studies?
Studies report effective management of clinical parameters such as blood urea nitrogen levels, with outcomes comparable to in-center dialysis.
What complications have been reported?
Safety data indicate typical hemodialysis risks like infection at the access site, but no unique complications specific to the device were reported.